 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > ICOS Corporation
 |
ICOS Corporation |
 |
 |
 |
NEWS FROM THE WIRES |
 |
ICOS posts narrower second quarter loss Jul 26 2001 01:57 PM PDT
Lilly ICOS says EU nixes Pfizer drug patent Jul 18 2001 02:33 PM PDT
ICOS, Biogen in oral therapeutics development pact Jul 16 2001 04:54 AM PDT
ICOS, Biogen in oral therapeutics development pact Jul 16 2001 04:54 AM PDT
Lilly, ICOS seek European approval of impotence drug Jul 12 2001 08:48 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
ICOS plans to get the blood flowing. Hoping to throw some cold water on Viagra's success, the firm has teamed with Eli Lilly to develop Cialis, which facilitates blood flow and is being developed as a treatment for both male and female sexual dysfunction. Other drug candidates include Pafase for severe sepsis, a potentially life-threatening bacterial infection, being developed with Japan's Suntory. The company has also teamed with Texas Biotechnology to develop therapies for cardiovascular conditions. Microsoft chairman and ICOS director Bill Gates owns about 10% of the firm, while George Rathmann, chairman of genome database developer Hyseq, owns about 5%.
COMPETITION |
 |
Bayer AG (BAYZY)
Eli Lilly and Company (LLY)
Pfizer Inc (PFE)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 90.70
1-Yr. Sales Growth: 13.9%
Employees: 386
Revenue per employee: $234,974.09
KEY PEOPLE |
 |
Paul N. Clark
CEO
Michael A. Stein
CFO
CONTACT INFO |
 |
22021 20th Ave. SE
Bothell, WA 98021
US
Phone: 425-485-1900
Fax: 425-489-0356
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |